HK216896A - Pharmaceutical preparations - Google Patents

Pharmaceutical preparations

Info

Publication number
HK216896A
HK216896A HK216896A HK216896A HK216896A HK 216896 A HK216896 A HK 216896A HK 216896 A HK216896 A HK 216896A HK 216896 A HK216896 A HK 216896A HK 216896 A HK216896 A HK 216896A
Authority
HK
Hong Kong
Prior art keywords
weight
denotes
pharmaceutical preparations
polyloxyethylene
pyrid
Prior art date
Application number
HK216896A
Other languages
English (en)
Inventor
Walter Fries
Original Assignee
Mack Chem Pharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mack Chem Pharm filed Critical Mack Chem Pharm
Publication of HK216896A publication Critical patent/HK216896A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
HK216896A 1989-11-29 1996-12-19 Pharmaceutical preparations HK216896A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3939492A DE3939492A1 (de) 1989-11-29 1989-11-29 Pharmazeutische zubereitungen

Publications (1)

Publication Number Publication Date
HK216896A true HK216896A (en) 1996-12-27

Family

ID=6394433

Family Applications (1)

Application Number Title Priority Date Filing Date
HK216896A HK216896A (en) 1989-11-29 1996-12-19 Pharmaceutical preparations

Country Status (29)

Country Link
US (1) US5118698A (xx)
EP (1) EP0430149B1 (xx)
JP (1) JPH0660097B2 (xx)
KR (1) KR940000066B1 (xx)
CN (1) CN1035357C (xx)
AT (1) ATE102051T1 (xx)
AU (1) AU626480B2 (xx)
BR (1) BR9006025A (xx)
CA (1) CA2030911C (xx)
CY (1) CY1970A (xx)
CZ (1) CZ282898B6 (xx)
DE (2) DE3939492A1 (xx)
DK (1) DK0430149T3 (xx)
EG (1) EG19557A (xx)
ES (1) ES2062271T3 (xx)
FI (1) FI103713B1 (xx)
HK (1) HK216896A (xx)
HU (1) HU220867B1 (xx)
IE (1) IE64672B1 (xx)
IL (1) IL96450A (xx)
MX (1) MX23518A (xx)
MY (1) MY104540A (xx)
NO (1) NO180475C (xx)
NZ (1) NZ236255A (xx)
PT (1) PT96003B (xx)
RU (1) RU2038080C1 (xx)
SK (1) SK595390A3 (xx)
YU (1) YU227290A (xx)
ZA (1) ZA909549B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2117642T3 (es) * 1990-05-10 1998-08-16 Bechgaard Int Res Preparado farmaceutico que contiene n-glicofuroles y n-etilen glicoles.
US5397771A (en) * 1990-05-10 1995-03-14 Bechgaard International Research And Development A/S Pharmaceutical preparation
JP3485540B2 (ja) * 2000-12-28 2004-01-13 新日本製鐵株式会社 低騒音トランス
EP1367997B1 (en) * 2001-02-28 2009-08-05 Intervet International BV Injectable water-in-oil emulsions
PT1471887E (pt) 2002-02-04 2010-07-16 Elan Pharma Int Ltd ComposiãŽes de nanopartculas com lisozima como um estabilizador superficial
WO2004006959A1 (en) * 2002-07-16 2004-01-22 Elan Pharma International, Ltd Liquid dosage compositions of stable nanoparticulate active agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1196284A (en) * 1982-05-28 1985-11-05 Joshua Oduro-Yeboah Pharmaceutical formulations
GR79307B (xx) * 1982-06-09 1984-10-22 Pfizer
DK476385A (da) * 1984-10-19 1986-04-20 Schering Corp 1,3-bis(1h-1,2,4-triazol-1-yl)-2-flour-2-(2,4-difluorphenyl)propan, antifungale midler indeholdende denne forbindelse, og fremgangsmaade til fremstilling af denne forbindelse

Also Published As

Publication number Publication date
HU220867B1 (en) 2002-06-29
YU227290A (sh) 1993-10-20
JPH03176421A (ja) 1991-07-31
KR940000066B1 (ko) 1994-01-05
EG19557A (en) 1997-08-31
IL96450A (en) 1994-10-21
DE3939492A1 (de) 1991-06-06
NO905106L (no) 1991-05-30
ZA909549B (en) 1992-06-24
ATE102051T1 (de) 1994-03-15
FI905814A0 (fi) 1990-11-26
FI905814A (fi) 1991-05-30
SK280599B6 (sk) 2000-04-10
BR9006025A (pt) 1991-09-24
CA2030911C (en) 1995-02-07
NO180475B (no) 1997-01-20
FI103713B (fi) 1999-08-31
AU6706590A (en) 1991-08-08
PT96003A (pt) 1991-09-13
CZ282898B6 (cs) 1997-11-12
RU2038080C1 (ru) 1995-06-27
CN1052046A (zh) 1991-06-12
CN1035357C (zh) 1997-07-09
PT96003B (pt) 1998-01-30
MX23518A (es) 1993-04-01
EP0430149A3 (en) 1991-09-25
HUT57039A (en) 1991-11-28
IE904282A1 (en) 1991-06-05
SK595390A3 (en) 2000-04-10
JPH0660097B2 (ja) 1994-08-10
MY104540A (en) 1994-04-30
NO905106D0 (no) 1990-11-26
DE69007029D1 (de) 1994-04-07
FI103713B1 (fi) 1999-08-31
KR910009286A (ko) 1991-06-28
EP0430149A2 (en) 1991-06-05
CY1970A (en) 1997-09-05
NO180475C (no) 1997-04-30
NZ236255A (en) 1992-02-25
IE64672B1 (en) 1995-08-23
US5118698A (en) 1992-06-02
EP0430149B1 (en) 1994-03-02
DE69007029T2 (de) 1994-06-09
ES2062271T3 (es) 1994-12-16
DK0430149T3 (da) 1994-03-28
AU626480B2 (en) 1992-07-30
CZ595390A3 (en) 1997-06-11
CA2030911A1 (en) 1991-05-30

Similar Documents

Publication Publication Date Title
AU6128590A (en) Novel compounds
ES2057016T3 (es) Compuestos de acido 3-pirrolidiniltio-1-azabiciclo (3.2.0) hept-2-eno-2-carboxilico.
AU6129890A (en) Novel compounds
ES513109A0 (es) "procedimiento de preparacion de derivados de 1-fenil-1-hidroxi-etilamina".
IE893653L (en) Compositions and compounds
IL114785A0 (en) Pyrrolocarbazoles their preparation and pharmaceutical compositions containing them
IL77717A (en) Pharmaceutical compositions containing derivatives of imidazole,their preparation and some novel compounds of this type
SE7906472L (sv) Nya 3-(aminoetyl)-fenol-derivat och salter derav, sett for framstellning och anvendning derav sasom lekemedel samt farmaceutiska kompositioner innehallande dessa foreningar
DE68917357D1 (de) Derivate der Coffeinsäure und pharmazeutische Zusammensetzungen, die sie enthalten.
ZA909549B (en) Pharmaceutical preparations
FI104071B (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisten 2,5-dihydro-2,5-diokso-1H-bents£b|atsepiinijohdannaisten valmistamiseksi
DK451389D0 (da) 2-substituerede 4,5-diaryl-thioimidazoler samt farmaceutisk praeparat indeholdende saadanne forbindelser
MX9206930A (es) Nuevos compuestos
ATE123487T1 (de) Derivate der kaffeinsäure und sie enthaltende pharmazeutische zusammensetzungen.
FR2682952B1 (fr) Nouveaux n-(mercaptoacyl) amino-acides, leur preparation et les compositions pharmaceutiques qui les contiennent.
SE8000699L (sv) Nya kinazolinderivat jemte sett for deras framstellning och farmaceutiska beredningar innehallande dem

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)